Ramzan I, Chan M
Department of Pharmacy, University of Sydney, Australia.
Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):273-6. doi: 10.1007/BF03188808.
The present study was undertaken to examine the effect of fluconazole on in vivo drug metabolism in rats, using the model substrate antipyrine. Oral doses of fluconazole, 20 mg/kg, were administered once (acutely) or twice daily for 4 days (chronically). Control animals received oral drug vehicle. Antipyrine kinetics were determined following an intravenous dose of 20 mg/kg given either 1 or 12 h after the single or last dose of fluconazole respectively. Acute fluconazole treatment significantly increased antipyrine half-life by 250% and reduced its clearance by 50%, without affecting its volume of distribution. Chronic treatment with fluconazole failed to affect antipyrine pharmacokinetics. This study demonstrates that acute fluconazole inhibits the metabolism of antipyrine in rats.
本研究旨在使用模型底物安替比林来检测氟康唑对大鼠体内药物代谢的影响。口服给予氟康唑,剂量为20mg/kg,单次给药(急性)或每日给药两次,共4天(慢性)。对照动物给予口服药物赋形剂。分别在单次或最后一剂氟康唑给药后1小时或12小时静脉注射20mg/kg安替比林后,测定安替比林的动力学。急性氟康唑治疗可使安替比林半衰期显著延长250%,清除率降低50%,而不影响其分布容积。氟康唑慢性治疗未能影响安替比林的药代动力学。本研究表明,急性氟康唑可抑制大鼠体内安替比林的代谢。